Disposal of European Starch facilities

| Filed in:

Tate & Lyle announces that, following completion of consultation with the European and local works councils and other employee representatives announced on 9 May 2007, it has entered into an agreement with Syral SAS (a subsidiary of Tereos of France) for the sale of its starch facilities in the UK, Belgium, France, Spain and Italy (together “the business”). The Belgian entity includes the head office, shared service centre and single billing entity in Aalst, Belgium (“SSC”) which is excluded from the sale. The disposal is subject to antitrust approval in Europe and completion is expected by 30 September 2007 at the earliest.

On completion, Tate & Lyle will receive a consideration of €310 million (£209 million) subject to closing adjustments relating to cash, debt, working capital and capital expenditure.

As set out in the Chairman's Annual General Meeting and Interim Management Statement published today, proceeds of the disposal are intended to be utilised as part of a share buy back programme.

In the year to 31 March 2007, the business had total sales of £520 million and a profit before interest and exceptional items of £38 million. At 31 March 2007 the business had gross assets of £253 million and net operating assets of £184 million. The disposal is expected to result in an exceptional loss of approximately £20 million after restructuring costs.

Iain Ferguson, Chief Executive, Tate & Lyle said, 'The sale of these starch facilities marks another important step in focusing Tate & Lyle's business on its value added strategy and reduces the impact of our exposure to volatile markets and to the EU sugar regime. I would like to take this opportunity to thank our employees at each of these facilities for their commitment and hard work over the years and wish them every future success.'

Citi acted as financial adviser to Tate & Lyle PLC.

Click here for our press image gallery

About Tate & Lyle PLC:  

Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.  

Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.  

Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 39 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.  

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2024, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2023, revenue for the enlarged Tate & Lyle Group would have been £2.25 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube